SEC ownership of GENELUX Corp

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001231457.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

2/50

Latest evidence

03 Nov 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
03 Nov 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001231457
Issuer location
Westlake Village, CA

Ownership snapshot

Top shareholders of GENELUX Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
2/50
Latest evidence
03 Nov 2026
13D/G 3/4/5 13F Lead comparable stake: 10% 48 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-8 of 50 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.

2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 2
ARMISTICE CAPITAL, LLC 10%
Aladar Szalay 6.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13D/G
10%
Reported 13D/G · 30 Sep 2025
$17,737,763
4,223,277 shares
$0 30 Sep 2025
Aladar Szalay
13D/G 3/4/5
10%+ Owner
6.2%
Reported 13D/G · 30 Sep 2026
$7,142,852
2,834,465 shares
-$755,549 30 Sep 2026
WOODWARD DIVERSIFIED CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$6,018,250
2,378,755 shares
— 30 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$4,202,317
1,660,995 shares
— 30 Sep 2026
Bleichroeder LP
13F
Company
13F
—
denominator unverified
$3,493,085
1,380,666 shares
— 30 Sep 2026
Thomas Zindrick
3/4/5
President and CEO
—
mixed-class rows
$3,007,848
1,673,338 shares
mixed-class rows
-$124,016 03 Nov 2026
Qian Zhang
3/4/5
Associate VP, Research
—
denominator unverified
$1,978,061
139,533 shares
— 17 Feb 2023
John Thomas
3/4/5
Director
—
mixed-class rows
$1,212,887
532,759 shares
mixed-class rows
-$108,766 16 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$340,565.

Buys
$0
Insiders: 0
Sells
$340,565
Insiders: 6
Net
-$340,565
Shares: -115,771
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 115,771
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 58,828 $0 $155,693 -$155,693
3-6 0 26,521 $0 $78,014 -$78,014
6-9 0 20,257 $0 $56,076 -$56,076
9-12 0 10,165 $0 $50,782 -$50,782

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to GENELUX Corp. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
Thomas Zindrick
Net 12M change
-$340.56KFull value: -$340,564 · USD · 12-month change
Latest report
03 Nov 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Thomas Zindrick President and CEO $3,007,848 -$124,016 -4% Mixed 03 Nov 2026
Qian Zhang Associate VP, Research $1,978,061 Mixed 17 Feb 2023
Aladar Szalay 10%+ Owner $1,553,120 Mixed 12 Sep 2024
John Thomas Director $1,212,887 -$108,766 -8.2% Mixed 16 Jun 2026
Matthew Pulisic Chief Financial Officer $674,952 Mixed 16 Jun 2026
Joseph Cappello Chief Technical Officer $648,431 -$35,391 -5.2% Filing P/S 03 Nov 2026
Eric Groen General Counsel $566,175 Mixed 16 Jun 2026
Yong Yu Chief Scientific Officer $518,955 -$33,915 -6.1% Filing P/S 03 Nov 2026
John W. Smither Director $265,818 -$34,898 -12% Filing P/S 01 Jul 2026
Mary Mirabelli Director $248,517 Mixed 16 Jun 2026
James L. Tyree Director $233,488 Mixed 16 Jun 2026
Ralph Smalling Head of Regulatory $198,100 -$3,578 -1.8% Filing P/S 03 Jun 2026
Lourie S. Zak Chief Financial Officer $192,938 Mixed 18 Dec 2024
Gabe Woodward Director $175,247 Mixed 17 Feb 2023
Sean Ryder General Counsel $139,053 Filing P/S 12 May 2025
Caroline Jewett Head of Quality $34,289 Filing P/S 19 Feb 2024
Doug Samuelson Vice President, Finance Mixed 11 Sep 2023
Paul Scigalla Chief Medical Officer Mixed 18 Oct 2024
Jason Litten Chief Medical Officer Mixed 02 Jan 2026

Recent insider transactions for GENELUX Corp

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Joseph Cappello GNLX Common Stock Sale -0.21% -$1,363 $2.04 -668 317,812 03 Nov 2026 Direct
Thomas Zindrick GNLX Common Stock Sale -0.25% -$6,317 $2.05 -3,089 1,223,338 03 Nov 2026 Direct
Yong Yu GNLX Common Stock Sale -0.26% -$1,344 $2.01 -668 258,020 03 Nov 2026 Direct
Joseph Cappello GNLX Common Stock Sale -3.12% -$28,112 $2.74 -10,257 318,480 31 Aug 2026 Direct
Thomas Zindrick GNLX Common Stock Sale -2.73% -$91,899 $2.67 -34,463 1,226,427 31 Aug 2026 Direct
Yong Yu GNLX Common Stock Sale -3.61% -$26,658 $2.75 -9,683 258,688 31 Aug 2026 Direct
Yong Yu GNLX Common Stock Sale -0.24% -$1,922 $2.94 -653 268,371 04 Aug 2026 Direct
Joseph Cappello GNLX Common Stock Sale -0.2% -$1,924 $2.95 -653 328,737 04 Aug 2026 Direct
Thomas Zindrick GNLX Common Stock Sale -0.24% -$8,905 $2.95 -3,023 1,260,890 04 Aug 2026 Direct
John W. Smither GNLX Common Stock Sale -11.6% -$34,898 $2.91 -12,000 91,403 01 Jul 2026 Direct
Matthew Pulisic GNLX Common Stock Award 278,906 278,906 16 Jun 2026 Direct
Eric Groen GNLX Common Stock Award 233,957 233,957 16 Jun 2026 Direct
Joseph Cappello GNLX Common Stock Award 113.1% 174,841 329,390 16 Jun 2026 Direct
James L. Tyree GNLX Common Stock Award 41.7% 28,409 96,483 16 Jun 2026 Direct
James L. Tyree GNLX Stock Option (Right to Buy) Award 31,566 31,566 16 Jun 2026 Direct
Thomas Zindrick GNLX Common Stock Award 137% 730,601 1,263,913 16 Jun 2026 Direct
John Thomas GNLX Common Stock Award 6.01% 28,409 501,193 16 Jun 2026 Direct
John Thomas GNLX Stock Option (Right to Buy) Award 31,566 31,566 16 Jun 2026 Direct
Mary Mirabelli GNLX Common Stock Award 38.2% 28,409 102,693 16 Jun 2026 Direct
Mary Mirabelli GNLX Stock Option (Right to Buy) Award 31,566 31,566 16 Jun 2026 Direct
Yong Yu GNLX Common Stock Award 79.7% 119,318 269,024 16 Jun 2026 Direct
John W. Smither GNLX Common Stock Award 37.9% 28,409 103,403 16 Jun 2026 Direct
John W. Smither GNLX Stock Option (Right to Buy) Award 31,566 31,566 16 Jun 2026 Direct
Ralph Smalling GNLX Common Stock Sale -0.28% -$563 $2.93 -192 67,611 03 Jun 2026 Direct
John Thomas GNLX Common Stock Sale -2.07% -$29,801 $2.98 -10,000 472,784 01 Jun 2026 Direct
Yong Yu GNLX Common Stock Sale -0.4% -$1,798 $2.97 -605 149,706 11 May 2026 Direct
Joseph Cappello GNLX Common Stock Sale -0.39% -$1,799 $2.97 -605 154,549 11 May 2026 Direct
Thomas Zindrick GNLX Common Stock Sale -0.52% -$8,226 $2.94 -2,798 532,051 11 May 2026 Direct
Ralph Smalling GNLX Common Stock Sale -0.4% -$804 $2.98 -270 67,803 11 May 2026 Direct
Ralph Smalling GNLX Common Stock Sale -0.35% -$602 $2.51 -240 68,073 25 Mar 2026 Direct
Ralph Smalling GNLX Common Stock Sale -0.5% -$835 $2.42 -345 68,313 24 Mar 2026 Direct
Joseph Cappello GNLX Common Stock Sale -0.58% -$2,193 $2.42 -906 155,154 24 Mar 2026 Direct
Yong Yu GNLX Common Stock Sale -0.62% -$2,193 $2.42 -906 144,938 24 Mar 2026 Direct
Thomas Zindrick GNLX Common Stock Sale -0.67% -$8,668 $2.42 -3,582 534,849 24 Mar 2026 Direct
John Thomas GNLX Common Stock Sale -2.03% -$28,957 $2.90 -10,000 482,784 02 Mar 2026 Direct
Jason Litten GNLX Stock Option (Right to Buy) Award 275,000 275,000 02 Jan 2026 Direct
Ralph Smalling GNLX Common Stock Sale -0.24% -$774 $4.69 -165 68,658 05 Dec 2025 Direct
John Thomas GNLX Common Stock Sale -1.99% -$50,008 $5.00 -10,000 492,784 01 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .